Pantothenamides Are Potent, On-Target Inhibitors of Plasmodium falciparum Growth When Serum Pantetheinase Is Inactivated
Open Access
- 6 February 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (2), e54974
- https://doi.org/10.1371/journal.pone.0054974
Abstract
Growth of the virulent human malaria parasite Plasmodium falciparum is dependent on an extracellular supply of pantothenate (vitamin B5) and is susceptible to inhibition by pantothenate analogues that hinder pantothenate utilization. In this study, on the hunt for pantothenate analogues with increased potency relative to those reported previously, we screened a series of pantothenamides (amide analogues of pantothenate) against P. falciparum and show for the first time that analogues of this type possess antiplasmodial activity. Although the active pantothenamides in this series exhibit only modest potency under standard in vitro culture conditions, we show that the potency of pantothenamides is selectively enhanced when the parasite culture medium is pre-incubated at 37°C for a prolonged period. We present evidence that this finding is linked to the presence in Albumax II (a serum-substitute routinely used for in vitro cultivation of P. falciparum) of pantetheinase activity: the activity of an enzyme that hydrolyzes the pantothenate metabolite pantetheine, for which pantothenamides also serve as substrates. Pantetheinase activity, and thereby pantothenamide degradation, is reduced following incubation of Albumax II-containing culture medium for a prolonged period at 37°C, revealing the true, sub-micromolar potency of pantothenamides. Importantly we show that the potent antiplasmodial effect of pantothenamides is attenuated with pantothenate, consistent with the compounds inhibiting parasite proliferation specifically by inhibiting pantothenate and/or CoA utilization. Additionally, we show that the pantothenamides interact with P. falciparum pantothenate kinase, the first enzyme involved in converting pantothenate to coenzyme A. This is the first demonstration of on-target antiplasmodial pantothenate analogues with sub-micromolar potency, and highlights the potential of pantetheinase-resistant pantothenamides as antimalarial agents.Keywords
This publication has 48 references indexed in Scilit:
- Global malaria mortality between 1980 and 2010: a systematic analysisThe Lancet, 2012
- Recent clinical and molecular insights into emerging artemisinin resistance in Plasmodium falciparumCurrent Opinion in Infectious Diseases, 2011
- Geminal dialkyl derivatives of N-substituted pantothenamides: Synthesis and antibacterial activityBioorganic & Medicinal Chemistry, 2011
- Synopsis of Some Recent Tactical Application of Bioisosteres in Drug DesignJournal of Medicinal Chemistry, 2011
- Antibacterial Activity of N -Pentylpantothenamide Is Due to Inhibition of Coenzyme A SynthesisAntimicrobial Agents and Chemotherapy, 2010
- Type II fatty acid synthesis is essential only for malaria parasite late liver stage developmentCellular Microbiology, 2009
- The Fatty Acid Biosynthesis Enzyme FabI Plays a Key Role in the Development of Liver-Stage Malarial ParasitesCell Host & Microbe, 2008
- Antibiotic evaluation and in vivo analysis of alkynyl Coenzyme A antimetabolites in Escherichia coliBioorganic & Medicinal Chemistry Letters, 2008
- Complex genetic control of susceptibility to malaria: positional cloning of the Char9 locusThe Journal of Experimental Medicine, 2007
- Nutritional Requirements of Plasmodium falciparum in Culture. I. Exogenously Supplied Dialyzable Components Necessary for Continuous GrowthThe Journal of Protozoology, 1985